Compounds > etomoxir
Page last updated: 2024-09-03

etomoxir and glucagon-like peptide 1

etomoxir has been researched along with glucagon-like peptide 1 in 1 studies

Compound Research Comparison

Studies
(etomoxir)		Trials
(etomoxir)		Recent Studies (post-2010)
(etomoxir)		Studies
(glucagon-like peptide 1)		Trials
(glucagon-like peptide 1)		Recent Studies (post-2010) (glucagon-like peptide 1)
2608939,4841,2086,374

Protein Interaction Comparison

ProteinTaxonomyetomoxir (IC50)glucagon-like peptide 1 (IC50)
Glucagon-like peptide 1 receptorHomo sapiens (human)0.0051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taegtmeyer, H1

Other Studies

1 other study(ies) available for etomoxir and glucagon-like peptide 1

ArticleYear
Cardiac metabolism as a target for the treatment of heart failure.
    Circulation, 2004, Aug-24, Volume: 110, Issue:8

    Topics: Acetanilides; Animals; Dogs; Energy Metabolism; Epoxy Compounds; Fatty Acids; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Insulin Resistance; Myocardium; Peptide Fragments; Piperazines; Protein Precursors; Ranolazine; Recombinant Proteins

2004